Compounds > naltrexone

naltrexone and Refractory Depression

naltrexone has been researched along with Refractory Depression in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bentzley, BS; Blasey, C; Hawkins, J; Heifets, BD; Lyons, DM; Schatzberg, AF; Sudheimer, KD; Williams, NR1
Eitan, S; Madison, CA1
Ho, RC; McIntyre, RS; Ragguett, RM; Rong, C; Rosenblat, JD1
Birnbaum, J; Blasey, C; Hawkins, J; Heifets, BD; Lyons, DM; Pankow, H; Pannu, J; Rodriguez, CI; Schatzberg, AF; Sudheimer, K; Williams, NR1
Barnes, DE; Marton, T; Wallace, A; Woolley, JD1
Du, Y; Ehrich, E; Fava, M; Fernandez, E; Jones, R; Leigh-Pemberton, R; Turncliff, R1

Reviews

2 review(s) available for naltrexone and Refractory Depression

ArticleYear
Buprenorphine: prospective novel therapy for depression and PTSD.
    Psychological medicine, 2020, Volume: 50, Issue:6

    Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Antidepressive Agents; Buprenorphine; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Combinations; Female; Humans; Male; Middle Aged; Naltrexone; Prospective Studies; Stress Disorders, Post-Traumatic; Young Adult

2020
Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder.
    Expert opinion on drug metabolism & toxicology, 2018, Volume: 14, Issue:4

    Topics: Antidepressive Agents; Buprenorphine; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Combinations; Humans; Naltrexone; Treatment Outcome

2018

Trials

2 trial(s) available for naltrexone and Refractory Depression

ArticleYear
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
    The American journal of psychiatry, 2018, 12-01, Volume: 175, Issue:12

    Topics: Adult; Antidepressive Agents; Cross-Over Studies; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ketamine; Male; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales

2018
Evaluation of opioid modulation in major depressive disorder.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:6

    Topics: Adult; Analgesics, Opioid; Antidepressive Agents; Buprenorphine; Cohort Studies; Cross-Over Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Treatment Outcome; Young Adult

2015

Other Studies

2 other study(ies) available for naltrexone and Refractory Depression

ArticleYear
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.
    Molecular psychiatry, 2019, Volume: 24, Issue:12

    Topics: Adult; Antidepressive Agents; Cross-Over Studies; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Receptors, Opioid; Suicidal Ideation; Suicide; Treatment Outcome

2019
Concurrent Use of Buprenorphine, Methadone, or Naltrexone Does Not Inhibit Ketamine's Antidepressant Activity.
    Biological psychiatry, 2019, 06-15, Volume: 85, Issue:12

    Topics: Adult; Aged; Analgesics, Opioid; Antidepressive Agents; Buprenorphine; Depressive Disorder, Treatment-Resistant; Female; Humans; Ketamine; Male; Methadone; Middle Aged; Naltrexone; Treatment Outcome

2019